Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes

Key Clinical Message Paroxysmal nocturnal hemoglobinuria is a rare disease with the incidence ranging from 0.08 to 0.57 per 100,000 person‐years. Up to 25% of cases in women are detected during pregnancy. We report two cases of successful pregnancy outcomes in patients treated with eculizumab, point...

Full description

Bibliographic Details

Published in:	Clinical Case Reports
Main Authors:	Jovanka Ilic, Borislava Pujic, Branislava Jakovljevic, Borivoj Sekulic, Danijela Agic, Amir El Farra, Branimir Micanovic, Tihomir Vejnovic, Ivana Urosevic, Aleksandar Savic
Format:	Article
Language:	English
Published:	Wiley 2024-05-01
Subjects:	eculizumab paroxysmal nocturnal hemoglobinuria PNH pregnancy
Online Access:	https://doi.org/10.1002/ccr3.8900